World Investment Advisors Acquires 2,512 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

World Investment Advisors increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,312 shares of the healthcare conglomerate's stock after purchasing an additional 2,512 shares during the period. World Investment Advisors' holdings in UnitedHealth Group were worth $24,779,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG raised its stake in shares of UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after purchasing an additional 9,872 shares in the last quarter. Proficio Capital Partners LLC raised its stake in shares of UnitedHealth Group by 52.1% in the 4th quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate's stock valued at $1,889,000 after purchasing an additional 1,279 shares in the last quarter. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $32,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Barclays dropped their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Mizuho reduced their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Truist Financial reiterated a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average price target of $415.57.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer owned 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH traded up $1.13 during trading hours on Friday, hitting $308.69. The company had a trading volume of 6,161,145 shares, compared to its average volume of 7,560,015. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market cap of $280.03 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.48 and a beta of 0.45. The business has a fifty day moving average of $324.99 and a 200-day moving average of $447.68. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.86%. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.